Shuo Huang1, Rui Wang2, Rong Li3, Haiyan Wang3, Jie Qiao4, Ben Willem J Mol5. 1. Center of Reproductive Medicine, Department of Obstetrics and Gynaecology, Peking University Third Hospital, Beijing, People's Republic of China; Robinson Research Institute and Adelaide Medical School, University of Adelaide, Adelaide, South Australia, Australia; Department of Obstetrics and Gynaecology, Monash University, Clayton, Victoria, Australia. 2. Robinson Research Institute and Adelaide Medical School, University of Adelaide, Adelaide, South Australia, Australia. 3. Center of Reproductive Medicine, Department of Obstetrics and Gynaecology, Peking University Third Hospital, Beijing, People's Republic of China. 4. Center of Reproductive Medicine, Department of Obstetrics and Gynaecology, Peking University Third Hospital, Beijing, People's Republic of China. Electronic address: jie.qiao@263.net. 5. Robinson Research Institute and Adelaide Medical School, University of Adelaide, Adelaide, South Australia, Australia; Department of Obstetrics and Gynaecology, Monash University, Clayton, Victoria, Australia.
Abstract
OBJECTIVE: To study the effectiveness of different ovarian stimulation protocols compared with natural cycle treatment in an intrauterine insemination (IUI) program. DESIGN: Retrospective cohort study. SETTING: Large reproductive medicine center. PATIENT(S): Couples with unexplained or mild male-factor infertility. INTERVENTION(S): Couples were treated with the use of natural-cycle IUI, or IUI after ovarian stimulation with the use of clomiphene citrate (CC), letrozole, or gonadotropins. MAIN OUTCOME MEASURE(S): Live birth, multiple pregnancy rates, and cumulative live birth rates after three IUI cycles. RESULT(S): We performed 14,519 IUI cycles in 8,583 couples. Compared with natural-cycle IUI (6.2%), live birth rates were significantly higher in IUI cycles stimulated with the use of CC (8.9%), letrozole (9.4%) and gonadotropins (9.5%). The multiple pregnancy rate resulting from natural cycles was 0.7%, compared with 4.6% in CC cycles, 1.3% in letrozole cycles, and 4.2% in gonadotropin cycles. Cumulative live birth rates after three IUI cycles were 18.4% after natural-cycle IUI, and 25.7%, 26.2%, and 23.7% with the use of CC, letrozole, and gonadotropins, respectively. CONCLUSION(S): In an IUI program for unexplained or mild male-factor infertility, ovarian stimulation with letrozole may significantly increase live birth rates while controlling multiple pregnancy rates.
OBJECTIVE: To study the effectiveness of different ovarian stimulation protocols compared with natural cycle treatment in an intrauterine insemination (IUI) program. DESIGN: Retrospective cohort study. SETTING: Large reproductive medicine center. PATIENT(S): Couples with unexplained or mild male-factor infertility. INTERVENTION(S): Couples were treated with the use of natural-cycle IUI, or IUI after ovarian stimulation with the use of clomiphene citrate (CC), letrozole, or gonadotropins. MAIN OUTCOME MEASURE(S): Live birth, multiple pregnancy rates, and cumulative live birth rates after three IUI cycles. RESULT(S): We performed 14,519 IUI cycles in 8,583 couples. Compared with natural-cycle IUI (6.2%), live birth rates were significantly higher in IUI cycles stimulated with the use of CC (8.9%), letrozole (9.4%) and gonadotropins (9.5%). The multiple pregnancy rate resulting from natural cycles was 0.7%, compared with 4.6% in CC cycles, 1.3% in letrozole cycles, and 4.2% in gonadotropin cycles. Cumulative live birth rates after three IUI cycles were 18.4% after natural-cycle IUI, and 25.7%, 26.2%, and 23.7% with the use of CC, letrozole, and gonadotropins, respectively. CONCLUSION(S): In an IUI program for unexplained or mild male-factor infertility, ovarian stimulation with letrozole may significantly increase live birth rates while controlling multiple pregnancy rates.
Authors: LaTasha B Craig; Sushila Arya; Heather R Burks; Kaitlin Warta; Christen Jarshaw; Karl R Hansen; Jennifer D Peck Journal: Fertil Steril Date: 2021-08-18 Impact factor: 7.329
Authors: Rui Wang; Nora A Danhof; Raissa I Tjon-Kon-Fat; Marinus Jc Eijkemans; Patrick Mm Bossuyt; Monique H Mochtar; Fulco van der Veen; Siladitya Bhattacharya; Ben Willem J Mol; Madelon van Wely Journal: Cochrane Database Syst Rev Date: 2019-09-05
Authors: Jennifer J Yland; Yu-Han Chiu; Paolo Rinaudo; John Hsu; Miguel A Hernán; Sonia Hernández-Díaz Journal: Hum Reprod Date: 2022-04-01 Impact factor: 6.918